Drug companies in general should have good earnings and there is news today about a Pepcid generic. The news says IVX has gotten 4 approvals with 34 more waiting. Fundamentals show yr-to-yr gains and looks like they have a 3rd Q down repeating cycle.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.